Philips and Dutch Isala Hospital renew long-term partnership focused on innovation and affordable, sustainable healthcare
August 13 2024 - 3:00AM
UK Regulatory
Philips and Dutch Isala Hospital renew long-term partnership
focused on innovation and affordable, sustainable healthcare
August 13, 2024
Amsterdam, The Netherlands – Royal Philips
(NYSE: PHG, AEX: PHIA), a global leader in health technology, and
Isala hospital (Zwolle, The Netherlands) have renewed their
long-term strategic partnership to enhance healthcare delivery
through innovative and cost-effective solutions. This collaboration
aims to ensure healthcare remains accessible, available, and
affordable by leveraging Philips' advanced technology, data
analytics, and AI. Focusing on the radiology and cardiology
departments, it follows a successful collaboration that began in
2012. The new agreement will last for five years, with an option to
extend for another five years.
Transforming healthcare with cutting-edge
technology
Isala will utilize Philips' technology to optimize processes and
deliver more patient-centered care. Together, they will integrate
new technologies into hospital operations and continuously improve
products based on real-world data-driven feedback.
"Our focus is on maintaining accessible, available, and
affordable care in a cost-effective way; the right technology plays
a crucial role in this," said Jules de Vet, a member of the Board
of Directors at Isala.
Sustainable and cost-effective medical systems
replacement
Isala will replace medical systems, such as MRI and CT scanners,
through a flexible multi-year plan ensuring cost-effectiveness and
sustainability. Continuous updates will keep systems
state-of-the-art, extending their lifespan and benefiting both
finances and the environment. Philips will provide essential
medical imaging systems and support services to improve clinical
adoption and streamline processes.
Enhancing clinical adoption of new
technology
"Hospitals face significant financial and personnel challenges in
the coming years, and there is no single solution to these
challenges," said Léon Kempeneers, Managing Director at Philips
Benelux. "Together with Isala, we will work on enhancing the
clinical adoption of new technologies such as AI, simplifying and
enhancing healthcare providers' work."
This renewed partnership underscores the commitment of Philips
and Isala to drive innovation and ensure sustainable, high-quality
healthcare delivery.
For further information, please contact:
Joost Maltha
Global External Relations
Tel. : +31 6 10558116
E-mail: joost.maltha@philips.com
Pieter de Meer
Philips Benelux
Tel. : +31625269065
E-mail: pieter.de.meer@philips.com
About Royal Philips
Royal Philips (NYSE:
PHG, AEX: PHIA) is a leading health technology company focused on
improving people's health and well-being through meaningful
innovation. Philips’ patient- and people-centric innovation
leverages advanced technology and deep clinical and consumer
insights to deliver personal health solutions for consumers and
professional health solutions for healthcare providers and their
patients in the hospital and the home. Headquartered in the
Netherlands, the company is a leader in diagnostic imaging,
ultrasound, image-guided therapy, monitoring and enterprise
informatics, as well as in personal health. Philips generated 2023
sales of EUR 18.2 billion and employs approximately 68,700
employees with sales and services in more than 100 countries. News
about Philips can be found at www.philips.com/newscenter.
- Isala Hospital The Netherlands
- Philips MR scanner
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Oct 2024 to Nov 2024
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Nov 2023 to Nov 2024
